Si-Bone Inc logo

SIBNSi-Bone Inc

NASDAQ · Healthcare · Medical Devices

$19.30

+$0.38 (+2.01%)

Si-Bone Inc (SIBN) is a medical devices company listed on NASDAQ. It is led by Laura A. Francis MBA, based in 471 El Camino Real, Santa Clara, CA, United States, 95050, with about 376 employees. SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Latest reported SIBN revenue for 2025-09-30 was $48.7M. Net income was -$4.6M. Revenue was up 0.1% from 2025-06-30 to 2025-09-30. SIBN currently screens at market cap $674.6M.

Use this SIBN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SIBN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SIBN SEC filings page. Lician reads the product cache first so this HTML stays unique to Si-Bone Inc even when a live quote feed is slow.

About Si-Bone Inc

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SIBN Key Statistics

Market Cap

$674.55M

Volume

600,032

Previous Close

$19.54

Day Range

$19.24$19.95

0

P/B Ratio

3.77

EPS

-$0.75

Revenue

$167.18M

Net Income

-$30.91M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+20.4%

Profit Margin

-18.5%

Employees

376

SIBN Financials

Annual income statement in USD. Latest reported periods first.

SIBN annual income statement across FY2024, FY2023, FY2022, FY2021
LineFY2024FY2023FY2022FY2021
Revenue$167.18M$138.89M$106.41M$90.15M
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$30.91M-$43.34M-$61.26M-$56.57M
EPS (Diluted)-$0.75-$1.13-$1.79-$1.71

Total Assets

$230.44M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$34.95M

Operating Cash Flow

-$12.43M

Free Cash Flow

$0.00

Si-Bone Inc Company Information

CEO & Director
Laura A. Francis MBA
Headquarters
471 El Camino Real, Santa Clara, CA, United States, 95050
Phone
408 207 0700
IPO / Founded
2018-10-17
Industry
Medical Devices
Data Updated:

Upcoming Events for SIBN